1
Home
Companies

Aura Biosciences

#7451

Rank

$406.75M

Marketcap

US United States

Country

Aura Biosciences
Leadership team

Dr. Elisabet de los Pinos Ph.D. (Founder, CEO, Pres & Director)

Ms. Julie B. Feder (CFO, Sec. & Treasurer)

Dr. Cadmus Collins Rich CPE, M.B.A., M.D., MBA (Chief Medical Officer and Head of R&D)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Cambridge, Massachusetts, United States
Established
2007
Company Registration
SEC CIK number: 0001501796
Traded as
AURA
Social Media
URL
https://www.aurabiosciences.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
History

Aura Biosciences was founded in 2013 by world-renowned ophthalmologist, Dr. David Brown. The company is based in Cambridge, MA, and is dedicated to discovering, developing, and commercializing transformative treatments to restore and preserve vision in the millions of people suffering from ocular diseases.

Mission
Our mission is to develop life-changing treatments to improve the lives of patients affected by serious ocular diseases.
Vision
Our vision is to be a leader in the development of therapies to cure or reverse the effects of serious ocular diseases.
Key Team

Dr. Mark A. De Rosch Ph.D. (Chief Operating Officer)

Mr. Joseph Lyons (VP of HR)

Mr. Paulo Carvalho (VP of Technical Operations)

Ms. Michele Keough M.B.A. (Sr. VP of Project Management and Device Supply Chain)

Recognition and Awards
Aura Biosciences has been recognized for its innovations with numerous awards, including the Medical Device and Diagnostic Industry's Breakthrough Technology Innovation award in 2016 and the Frost & Sullivan Award for New Product Innovation in 2017.
References

https://en.wikipedia.org/wiki/Aurora_Biosciences

https://in.investing.com/equities/aura-biosciences

https://finance.yahoo.com/quote/AURA/profile?p=AURA

https://www.crunchbase.com/organization/aura-biosciences

https://companiesmarketcap.com/

https://www.aurabiosciences.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Aura Biosciences
Leadership team

Dr. Elisabet de los Pinos Ph.D. (Founder, CEO, Pres & Director)

Ms. Julie B. Feder (CFO, Sec. & Treasurer)

Dr. Cadmus Collins Rich CPE, M.B.A., M.D., MBA (Chief Medical Officer and Head of R&D)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Cambridge, Massachusetts, United States
Established
2007
Company Registration
SEC CIK number: 0001501796
Traded as
AURA
Social Media
URL
https://www.aurabiosciences.com